Literature DB >> 15888753

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia.

M Hallek1, R A Stahel, R Greil.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15888753     DOI： 10.1093/annonc/mdi806

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Improvement of hospital care for patients with non-Hodgkin's lymphoma: protocol for a cluster randomized controlled trial (PEARL study).

Authors:  Jozette J C Stienen; Rosella P M G Hermens; Lianne Wennekes; Saskia A M van de Schans; Helena M Dekker; Nicole M A Blijlevens; Richard W M van der Maazen; Eddy M M Adang; Johan H J M van Krieken; Petronella B Ottevanger
Journal:  Implement Sci       Date:  2013-07-09       Impact factor: 7.327

2.  Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia.

Authors:  Adil Nazir; Sheeraz Ali; Farhana Badar; Neelam Siddique; Abdul Hameed
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

3.  Alemtuzumab in chronic lymphocytic leukemia.

Authors:  G Fraser; C A Smith; K Imrie; R Meyer
Journal:  Curr Oncol       Date:  2007-06       Impact factor: 3.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.